BUYER READINESS
MEDDIC is the most rigorous qualification framework in B2B sales. If you're running it well, you know more about your pipeline than 90% of your competitors. You disqualify bad deals faster. You build forecasts on evidence instead of hope. That discipline is real.
And it's not preventing the problem you're seeing.
A deal checks every box. Metrics confirmed. Economic Buyer identified. Champion engaged. Pain quantified. Decision Process mapped. Three weeks after the demo, silence. Not because MEDDIC failed. Because MEDDIC was never designed to measure whether the buyer has completed the internal work required to say yes.
Most B2B revenue problems get solved at the seller level. DecisionScope exists because the real bottleneck is on the buyer side, and nobody had built an instrument to measure it.
What MEDDIC Measures (And Why It Earned Its Place)
MEDDIC tracks six elements of deal qualification: Metrics, Economic Buyer, Decision Criteria, Decision Process, Identify Pain, and Champion. MEDDPICC adds Paper Process and Competition. Together, they answer one question: does this deal have the conditions to close?
That question matters more than most sales leaders realize. Teams running MEDDIC disqualify bad deals faster, allocate resources more intelligently, and build forecasts grounded in confirmed data points rather than rep optimism. The framework earned its place in enterprise sales over three decades because it works for what it was built to do.
The key insight is in those last seven words. MEDDIC is seller-side intelligence at its best. It maps the deal's conditions from the outside. It tells your rep what to confirm. It does not tell your rep what the buyer hasn't resolved on the inside.
The Gap Between Qualification and Decision
If you've run MEDDIC well and deals still stall, the instinct is to assume your team isn't running it well enough. That's usually not the problem.
MEDDIC confirms an Economic Buyer exists. It doesn't check whether that buyer has resolved their own hesitation about acting. A VP can have full budget authority and still not be ready to spend it, because they haven't internalized the cost of doing nothing.
MEDDIC confirms Pain has been identified. It doesn't check whether the buyer has internalized that pain deeply enough to prioritize this decision over the fourteen other priorities competing for their attention this quarter. Kahneman and Tversky established that buyers feel losses approximately 2.25 times more intensely than equivalent gains. But loss aversion only works if the buyer has internalized the loss. Without that conviction, pain sits in your CRM as a confirmed data point and in the buyer's mind as an acknowledged fact they haven't acted on.
MEDDIC confirms a Champion is in place. It doesn't check whether that champion can build consensus in a buying group that averages 13 stakeholders across multiple departments, where 74% of teams demonstrate unhealthy conflict during the decision process. Your champion said yes. That's one person in a room of thirteen, and nine of them have concerns nobody has mapped.
The data makes this gap visible. Between 40% and 60% of qualified B2B deals end in no decision. Not lost to a competitor. Abandoned by a buyer who couldn't complete the decision. 56% of those losses come from buyer indecision, not a deliberate preference for the status quo. And when sellers respond by pushing harder, win rates degrade by 84%.
These aren't unqualified deals. They passed the MEDDIC check. They had metrics, an economic buyer, a champion, confirmed pain. They died because qualification measures whether the conditions are right. It doesn't measure whether the buyer is ready.
The Dimensions MEDDIC Wasn't Built to Measure
MEDDIC's blind spot is most acute in two of the four buyer readiness dimensions: Organizational Readiness and Problem Conviction.
Organizational Readiness measures whether the buying group can align and close. MEDDIC identifies the Champion and maps the Decision Process. It doesn't measure whether the champion has a strategy for the twelve other stakeholders, whether the CFO is a silent blocker, or whether the committee has the internal alignment required to approve. 86% of B2B purchases stall during the buying process. Most of those stalls happen here, in the space between a confirmed champion and an aligned buying group.
Problem Conviction measures whether the buyer has internalized the cost of inaction enough to act. MEDDIC confirms pain exists. It doesn't measure the distance between "we know this is a problem" and "we are going to do something about this problem right now." That distance is where urgency lives or dies, and it's invisible to qualification.
The full four-dimension framework also measures Evaluation Clarity and Outcome Confidence. The four dimensions form a chain. The deal moves at the speed of the weakest link. Three dimensions at full strength plus one incomplete equals a dead deal. That's the pattern hiding inside your MEDDIC-qualified pipeline.
How Qualification and Diagnosis Work Together
MEDDIC says: “This deal is qualified.” DecisionScope says: “This buyer is ready to decide.”
Both statements can be true. Both can be false. The dangerous combination is the first being true while the second is false. That's the deal your forecast counts on that quietly disappears.
Here's what that looks like in practice. MEDDIC says the champion is identified and pain is confirmed. The deal is in Stage 3, tracking toward a demo next week. Everything checks out.
DecisionScope reveals: Problem Conviction confirmed. Evaluation Clarity confirmed. Outcome Confidence confirmed. Organizational Readiness sitting at 2 out of 5. The champion has no stakeholder map. They haven't identified the CFO as a silent blocker. They have no internal selling materials. Three dimensions passed. The fourth kills the deal. They're going to say “let me run this by my team” after the demo, and you won't hear from them for three weeks. By then the quarter has moved on and the deal is dead.
With the MEDDIC qualification alone, your team would have pushed forward. With the DecisionScope diagnostic, your team applies the Consensus Protocol: map the buying group, identify the conflict sources, equip the champion with stakeholder-specific materials before the demo happens. Different intervention. Different outcome.
The research validates this layered approach. Dixon and McKenna found a 14% close rate when sellers only diagnosed the problem without prescribing a resolution. When diagnosis was paired with a specific protocol recommendation, close rates jumped to 36%. Knowing the gap exists isn't enough. Knowing which protocol resolves it is what moves the number.
When to Use Which
Use MEDDIC to decide which deals deserve your team's resources. Qualification prevents your reps from spending 45-minute demos on prospects who don't have budget authority or a defined decision process. That discipline is indispensable.
Use DecisionScope to diagnose why qualified deals stall and identify which specific protocol resolves the gap. When the deal passes qualification but the buyer goes quiet, the answer isn't “push harder.” The answer is diagnosing which readiness dimension is incomplete and applying the right resolution before silence becomes permanent.
Use both for the highest-fidelity pipeline intelligence available. Qualify first, then diagnose readiness before the demo. The result: fewer surprises in your forecast, fewer qualified deals dying in committee, and specific action plans for every stalled deal instead of generic follow-up sequences.
Whatever qualification framework your team runs, DecisionScope adds the readiness layer beneath it.
Take the free Buyer Readiness Check → Score your pipeline across four dimensions in under five minutes.
Frequently Asked Questions
Does DecisionScope replace MEDDIC?
No. DecisionScope is a diagnostic layer beneath MEDDIC, not a replacement. MEDDIC qualifies the deal's conditions: metrics, economic buyer, decision criteria, champion, pain. DecisionScope measures whether the buyer has completed the internal decisions that make those conditions actionable. A deal can pass every MEDDIC criterion and still die because the buyer never resolved their outcome uncertainty or organizational alignment. The two instruments measure different things. Use both.
Can I use DecisionScope with MEDDPICC?
Yes. MEDDPICC adds Paper Process and Competition to the standard MEDDIC framework, which strengthens qualification. DecisionScope adds the readiness layer that neither MEDDIC nor MEDDPICC covers: whether the buyer has reached conviction, clarity, confidence, and organizational consensus. The additional MEDDPICC fields are complementary to the DecisionScope dimensions, not overlapping.
What's the difference between deal qualification and buyer readiness?
Deal qualification asks: does this opportunity have the right conditions to close? Budget exists, decision-maker identified, pain confirmed, timeline established. Buyer readiness asks: has the buyer completed the internal work required to say yes? Problem conviction internalized, evaluation framework in place, outcome confidence established, buying group aligned. A deal can be fully qualified and completely unready. That gap is where 40-60% of qualified pipeline goes to die.
How long does a DecisionScope assessment take?
The free Buyer Readiness Check takes under five minutes and provides preliminary readiness scores across all four dimensions. A full DecisionScope diagnostic covers individual deal scoring with evidence documentation and protocol recommendations. Timeline varies based on pipeline scope and complexity.